)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Lineage Cell Therapeutics
Lineage Cell Therapeutics (LCTX) investor relations material
Lineage Cell Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Voting matters and shareholder proposals
Shareholders will vote to elect seven directors to serve until the 2027 annual meeting and until successors are elected and qualified.
Proposal to ratify Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote on the compensation paid to named executive officers is included.
Board recommends voting for all director nominees and for proposals 2 and 3.
Other business may be transacted as properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Seven director nominees are listed: Michael H. Mulroy, Dipti Amin, Deborah Andrews, Neal C. Bradsher, Brian M. Culley, Anula Jayasuriya, and Angus C. Russell.
Executive compensation and say-on-pay
Advisory vote will be held regarding the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lineage Cell Therapeutics
- Director elections, auditor ratification, and executive pay approval headline the 2026 meeting.LCTX
Proxy filing29 Apr 2026 - Scalable allogeneic cell therapies advance in ophthalmology and spinal cord injury with strong partnerships.LCTXCorporate presentation26 Mar 2026
- Biotech seeks to raise up to $100M for cell therapy R&D and growth via flexible shelf registration.LCTXRegistration Filing11 Mar 2026
- Milestone payments, clinical progress, and funding extend runway into 2028 despite higher net loss.LCTXQ4 20256 Mar 2026
- Q2 2024 saw a $5.8M net loss, $1.4M revenue, and cash runway into Q4 2025 as OpRegen advanced.LCTXQ2 20242 Feb 2026
- Durable vision gains and retinal restoration in dry AMD drive major cell therapy advances.LCTXH.C. Wainwright 4th Annual Ophthalmology Virtual Conference2 Feb 2026
- Q3 net loss narrowed to $3M, cash funds operations into Q1 2026, OpRegen advanced with RMAT.LCTXQ3 202414 Jan 2026
- Durable OpRegen results, improved financials, and strong cash position support future growth.LCTXQ4 202417 Dec 2025
- OpRegen and OPC1 show durable clinical gains, pipeline growth, and manufacturing advances.LCTXOppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 202516 Dec 2025
Next Lineage Cell Therapeutics earnings date
Q1 202612 May, 2026
Lineage Cell Therapeutics
Next Lineage Cell Therapeutics earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage